COVID-19大流行对不同流行条件下常规疫苗接种覆盖率的影响:中国北京一项队列研究
该研究在北京开展回顾性人群队列研究,按出生日期分层随机抽样纳入29,811名儿童,按疫苗 Eligibility 时期分为四组,随访1个月,用Cox比例风险模型分析COVID-19疫情状态与及时接种的关联。结果显示低流行期及时接种率较高(HR 1.18,95%CI 1.15-1.22),激增期较低(HR 0.73,95%CI 0.66-0.82),放缓期与疫情前无显著差异(HR 0.99,95%CI 0.91-1.09)。
要点
- COVID-19低流行期组及时接种率高于疫情前组(HR 1.18,95%CI 1.15-1.22)。
- COVID-19激增期组及时接种率低于疫情前组(HR 0.73,95%CI 0.66-0.82)。
- 截至2023年5月底,激增期组DTP3覆盖率超过90%。
核心结论
- COVID-19激增期(持续两个月)及时接种率显著下降,而近三年的低流行期未出现下降。
- 及时接种率随后呈上升趋势,并在后续3-4个月内恢复至基线水平。
- 作者认为大流行对中国常规免疫覆盖率的影响呈下降但可恢复的趋势。
研究设计与样本
- 回顾性、人群为基础的队列研究,在中国北京开展。
- 采用按出生日期分层随机抽样,获得29,811名参与者样本。
- 按疫苗 Eligibility 时期分为四组:疫情前组、COVID-19低流行期组、COVID-19激增期组、COVID-19放缓期组。
- 进行了一个月的随访,采用Cox比例风险模型分析COVID-19疫情状态与及时接种的关联。
主要发现
- COVID-19低流行期组及时接种率高于疫情前组(HR 1.18,95%CI 1.15-1.22)。
- COVID-19激增期组及时接种率低于疫情前组(HR 0.73,95%CI 0.66-0.82)。
- COVID-19放缓期组与疫情前组相比,及时接种率无显著差异(HR 0.99,95%CI 0.91-1.09)。
- 截至2023年5月底,COVID-19激增期组中符合条件儿童的DTP3覆盖率超过90%。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The COVID-19 pandemic has experienced various phases including outbreaks, a global health crisis, and eventual de-escalation from a public health emergency of international concern, significantly affecting the delivery and utilization of healthcare services. This study aimed to evaluate the impact of the COVID-19 pandemic on the coverage rate of routine immunization in children under varying prevalence conditions. METHODS: We conducted a retrospective, population-based cohort study in Beijing, China, utilizing stratified random sampling by birthdate to obtain a sample of 29,811 participants. Subjects were categorized into four cohorts based on when they became eligible for vaccination: the Pre-COVID Period cohort, the COVID-19 Low Epidemic Period cohort, the COVID-19 Surging Period cohort, and the COVID-19 Slowing Down Period cohort. A one-month follow-up was conducted. Cox proportional hazards model was employed to examine associations between the COVID-19 epidemic status and timely vaccination. RESULTS: Participants age-eligible for vaccination during the COVID-19 Low Epidemic Period demonstrated higher rates of timely vaccination (HR 1.18, 95% CI 1.15-1.22) compared to those eligible during the Pre-COVID Period. Conversely, those eligible during the COVID-19 Surging Period displayed lower rates (HR 0.73, 95% CI 0.66-0.82). No significant difference in vaccination timeliness was observed for those eligible during the COVID-19 Slowing Down Period in comparison to the Pre-COVID Period (HR 0.99, 95% CI 0.91-1.09). By the end of May 2023, DTP3 rate among eligible children during the COVID-19 Surging Period had surpassed 90%. CONCLUSIONS: Significantly declining rates of timely vaccination were observed during the COVID-19 Surging Period, which lasted two months, but not during the nearly three-year-long COVID-19 Low Epidemic Period. An upward trend in vaccination timeliness followed, culminating in a return to baseline levels over the subsequent 3-4 months. Our findings suggested that the pandemic exerted a decreasing and recoverable impact on the coverage rate of routine immunizations in China.
引用
- Cao Z, Yu R, Yuan Q, et al. Impact of the COVID-19 pandemic on routine vaccination coverage under varying prevalence Conditions: A cohort study in Beijing, China. Vaccine. 2023. PMID: 38097454. doi:10.1016/j.vaccine.2023.12.014
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。